Patient Numbers at NIH Hospital Have Dropped Significantly
NIH documents viewed by KFF Health News show a pronounced decline in patients at the 200-bed NIH hospital from February through April
Read More
Leapfrog Group Finds Significant Improvements in Patient Safety
Fall 2024 Hospital Safety Grade report sees reductions in healthcare-associated infections nationwide
Healthcare collections for mid-size providers
Today’s patients are used to the seamless and transparent payment processes in retail services. It’s no surprise that they expect the same convenience with paying for healthcare. According to Experian Health’s State of Patient Access 2024 report, 96% emphasized that it is crucial they receive an accurate estimate of treatment costs before service. In fact,…
Voters in These Red States Okay Paid Sick Leave
Voters in Missouri and Nebraska approved ballot measures Tuesday that guarantee paid leave for sick workers. Alaska voters seem poised to pass a similar measure that has a wide lead. These two Republican-led states join 15 others and D.C. — largely Democratic-controlled places — in requiring some employers to provide workers with paid sick leave. Proponents cheered…
How Much Will That Surgery Cost? 🤷 Hospital Prices Remain Largely Unhelpful.
It’s a holy grail of health care: forcing the industry to reveal prices negotiated between health plans and hospitals — information that had long been treated as a trade secret. And among the flurry of executive orders President Donald Trump signed during his first five weeks back in office was a promise to “Make America…
NextGen Healthcare, Kno2 Form Partnership to Improve Patient Care and Advance Interoperability
NextGen and Kno2 are leveraging Kno2’s QHIN to streamline data exchange
How is AI transforming the pharmaceutical industry?
The Economist reports that many life science companies are betting big on AI to help with drug development. Why? If AI can increase their likelihood new molecules become successful drugs, the cost of drug development will fall. AI-designed molecules show an 80-90% success rate in early-stage safety trials, compared with a historical average of just…
The EU pharmaceutical package and most-favored nation pricing – A paradox in European policy design
In my latest Guest Column in The Evidence Base, II am joined by my colleague Tiago Beck as we examine how global pricing reforms are reshaping the European pharmaceutical landscape. Building on their session at ISPOR Europe 2025, the column explores the growing tension between EU access ambitions and international policy pressures – offering a…
At Little-Known Health Agency, DOGE Ends Dream ‘To Make A Difference’
By MICHAEL MILLENSON Four days after emergency surgery and barely able to walk, Heather Sherman flew from Chicago to Washington for first-day-of-work onboarding at the Agency for Healthcare Research and Quality. Fourteen months later, Sherman suddenly became one of the thousands of federal employees summarily dismissed by a weekend email telling them they were “not…
Medigap May Be Elusive for Medicare Beneficiaries with Pre-Existing Conditions
This issue brief analyzes federal and state guaranteed issue rules and how they impact beneficiaries’ access to Medigap, including the implications for Medicare beneficiaries with pre-existing conditions and those under age 65 with long-term disabilities. This brief also explores a recently finalized rule: Nondiscrimination in Health Programs and Activities regarding Section 1557 of the Affordable…